Leading Veterinary Biotech Company, Hilltop Bio to Sponsor Dressage at Devon
Dressage at Devon is proud to announce Hilltop Bio as a sponsor of Dressage at Devon presented by Kingsview Partners, held at the prestigious Devon Horse Show grounds from September 26 to October 1, 2023. Hilltop Bio is a veterinary biotech company committed to developing innovative regenerative therapies that improve the lives of animals.
The company has seen success with its regenerative therapy products made for wounds, joint injections, soft tissue injuries, eye drops, and summer sores. The company specializes in making products from birth tissue which is rich in specific proteins and growth factors. Traditional modalities for soft tissue and joint injections include PRP, IRAP, and ProStride. Hilltop Bio is focused on the next generation of cutting edge regenerative therapies which are backed by science, recommended by vets and trusted by owners, help deliver fast, reliable results, and are competition safe.
“As a dressage rider myself, my team and I are very excited to sponsor Dressage at Devon this year! This will be our first time at the show as a sponsor and we are looking forward to supporting the dressage community with world class riders and horses.” Hilltop Bio, CEO, Amanda Drobnis
Hilltop Bio’s sponsorship will include a hot pink branded tent in front of the office as well as staff outfitted in Hilltop Bio shirts. There will be giveaways for horse and rider, so be sure to stop by!
Wednesday evening’s lecture by New Bolton veterinarians is sponsored by Hilltop Bio as well. The talks will feature two talks, “What is Equine Degenerative Myeloencephalopathy (EDM)? Find out what we’re learning from head to tail.” and “Want to compete your mare and breed her too? Learn the Ins and Outs of ICSI (Intracytoplasmic sperm injection)!” Heavy hors d’oeuvres and refreshments will be served. Please register in advance here.
About Hilltop Bio
Hilltop Bio is a veterinary biotech company developing innovative regenerative therapies focused on helping our four-legged friends reduce inflammation from injuries or disease. The company’s strategy is to identify key inflammatory diseases in companion and performance animals and work to provide targeted regenerative therapies to help reduce inflammation and normalize the damaged tissue function. Hilltop Bio has developed a strong pipeline of innovative therapies across many therapeutic classes, alongside cGMP, cGTP manufacturing capabilities and a developing intellectual property portfolio. To learn more about Hilltop Bio, visit their website HilltopBio.com and look for them on Facebook, Instagram, and LinkedIn.